AWS Public Sector Blog
Author: Dr. Jeremy Lim
Professor Jeremy Lim is chief executive officer (CEO) and co-founder of AMILI, the first gut microbiome company centered in Singapore serving the region. Jeremy is active in the community: he chairs the steering committee of NIHA (NUS Initiative to Improve Health in Asia), an initiative to strengthen health policy research and education in Asia
AMILI helps advance precision medicine by building microbiome library on AWS
AMILI is a healthcare technology (HealthTech) company based in Singapore that seeks to advance precision medicine and personalized health and nutrition by harnessing the potential of the microbiome. AMILI uses artificial intelligence (AI) and machine learning (ML) on AWS to comprehensively quantify and characterize gut microbiomes. AMILI aims to build and curate the world’s largest multi-ethnic Asia microbiome database.